See how top analysts and institutions rate CAG — including buy, hold, and sell recommendations.
| Rating Source | Action | Rating | Target Price | Updated |
|---|---|---|---|---|
| JP Morgan | Resumed | Neutral | $20 | 2025-08-20 |
| UBS | Initiated | Neutral | $22 | 2025-06-16 |
| BofA Securities | Downgrade | Neutral → Underperform | $20 | 2025-06-12 |
| Goldman | Downgrade | Neutral → Sell | $21 | 2025-06-09 |
| Date | Strong Buy | Buy | Hold | Sell | Strong Sell |
|---|---|---|---|---|---|
| November 2025 | 3 | 0 | 12 | 1 | 1 |
| October 2025 | 3 | 0 | 13 | 1 | 1 |
| September 2025 | 3 | 0 | 13 | 1 | 1 |
| July 2025 | 3 | 0 | 13 | 1 | 1 |
The majority of institutional investors have issued a "Buy" rating for CAG, and analyst sentiment aligns closely, with very few "Sell" recommendations. This suggests a broadly favorable outlook for the stock's performance.
